Clinical Scorecard: Aqueous cytology may diagnose iris metastasis without biopsy
At a Glance
| Category | Detail |
|---|---|
| Condition | Iris metastasis from lung adenocarcinoma |
| Key Mechanisms | Aqueous humor cytology identifies atypical glandular epithelial cells indicative of metastatic disease. |
| Target Population | Patients with lung adenocarcinoma and suspected iris metastasis. |
| Care Setting | Ophthalmology and oncology clinics. |
Key Highlights
- Aqueous humor cytology can diagnose iris metastasis without biopsy.
- Cytologic findings classified as Class V indicate metastatic adenocarcinoma.
- Initial treatment for secondary glaucoma included topical medications and acetazolamide.
- Transscleral cyclophotocoagulation was performed after IOP increase.
- Negative cytology does not exclude metastatic disease; repeat sampling may be necessary.
Guideline-Based Recommendations
Diagnosis
- Consider aqueous humor cytology for diagnosing iris metastasis in selected patients.
Management
- Manage secondary glaucoma with topical medications and surgical interventions as needed.
Monitoring & Follow-up
- Follow-up for progression of iris tumors and systemic disease.
Risks
- False-negative results may occur depending on tumor burden and sampling volume.
Patient & Prescribing Data
Patients with lung adenocarcinoma presenting with ocular symptoms.
Combination of medical and surgical management is often required for secondary glaucoma.
Clinical Best Practices
- Repeat aqueous humor sampling or consider iris biopsy if clinical suspicion remains high.
- Systemic restaging should be performed in cases of suspected metastasis.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
